Experience and qualifications
David Issott is a Principal in the Healthcare team. He
originally joined Apax Partners in 2004 in London and
relocated to New York in 2010.
To date, he has been involved in various
investments including Marken, Qualitest Pharmaceuticals, Xanodyne,
Kwik Save and Healthcare at Home.
David currently sits on the Boards of
Marken, a leading provider of specialised logistics and support
services companies to the biopharmaceutical industry,
and Qualitest Pharmaceuticals, which provides affordable,
high-quality generic pharmaceuticals and is amongst the top ten US
domestic producers.
Prior to joining Apax, David worked in
healthcare M&A at Lazard. Prior to Lazard he was at LEK
Consulting. He graduated from Oxford University with a first class
Masters degree in Chemistry.
Investments
Investments include:
Marken
Leading global provider of specialised logistics and support
services to the pharmaceutical industry
Qualitest Pharmaceuticals
Manufacturer and distributor of generic pharmaceuticals in the
US
Current directorships
Marken
Leading global provider of specialised logistics and support
services to the pharmaceutical industry
Qualitest Pharmaceuticals
Manufacturer and distributor of generic pharmaceuticals in the
US